Featured Research

from universities, journals, and other organizations

Predicting Mosquito Outbreaks For Disease Control

Date:
March 31, 2009
Source:
University of Adelaide
Summary:
Researchers in Australia have shown they can predict the biggest population peaks of disease-carrying mosquitoes up to two months ahead.

University of Adelaide researchers have shown they can predict the biggest population peaks of disease-carrying mosquitoes up to two months ahead.

This should help the fight against outbreaks of serious mosquito-borne disease like dengue and Ross River fever by allowing efficient and cost-effective mosquito control, says ecologist Associate Professor Corey Bradshaw.

"The risk of disease transmission is highest when mosquitoes are at their most abundant," says Associate Professor Bradshaw, who is from the University's School of Earth and Environmental Sciences and also employed as a Senior Scientist by the South Australian Research and Development Institute (SARDI).

"This model is a tool that helps predict when there is going to be a higher-than-average outbreak so that population control efforts can be implemented when they are going to be most effective and are most needed."

The University of Adelaide researchers analysed 15 years of population data of Aedes vigilax , the northern Australian mosquito that transmits the Ross River and Barmah Forest viruses, and compared it with environmental factors affecting populations including tides and rainfall.

"We found that basic environmental monitoring data can be coupled with relatively simple population models to assist in predicting the timing and magnitude of mosquito peaks which lead to disease outbreaks in human populations," Associate Professor Bradshaw says.

In salt-loving species like the Aedes vigilax mosquito, populations tend to peak after very high tides. But the frequency of high tides and the amount of rainfall in the preceding months when mosquito numbers are low are the critical elements dictating the magnitude of eventual peaks.

"Previously, we didn't know how big that peak would be," says Associate Professor Bradshaw. "With this model, mosquito control efforts can be scaled according to the expected size of a future peak."

Associate Professor Bradshaw said the same model could be applied to other mosquito species, for instance dengue- or malaria-transmitting species, and others in tropical regions worldwide.

The research is detailed in a paper published online in the Public Library of Science journal PLOS Neglected Tropical Diseases.


Story Source:

The above story is based on materials provided by University of Adelaide. Note: Materials may be edited for content and length.


Journal Reference:

  1. Guo-Jing Yang, Barry W. Brook, Corey J. A. Bradshaw. Predicting the Timing and Magnitude of Tropical Mosquito Population Peaks for Maximizing Control Efficiency. PLoS Neglected Tropical Diseases, 2009; 3 (2): e385 DOI: 10.1371/journal.pntd.0000385

Cite This Page:

University of Adelaide. "Predicting Mosquito Outbreaks For Disease Control." ScienceDaily. ScienceDaily, 31 March 2009. <www.sciencedaily.com/releases/2009/03/090324101757.htm>.
University of Adelaide. (2009, March 31). Predicting Mosquito Outbreaks For Disease Control. ScienceDaily. Retrieved July 22, 2014 from www.sciencedaily.com/releases/2009/03/090324101757.htm
University of Adelaide. "Predicting Mosquito Outbreaks For Disease Control." ScienceDaily. www.sciencedaily.com/releases/2009/03/090324101757.htm (accessed July 22, 2014).

Share This




More Health & Medicine News

Tuesday, July 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com
$23.6 Billion Awarded To Widow In Smoking Lawsuit

$23.6 Billion Awarded To Widow In Smoking Lawsuit

Newsy (July 20, 2014) Cynthia Robinson claims R.J. Reynolds Tobacco Company hid the health and addiction risks of its products, leading to the death of her husband in 1996. Video provided by Newsy
Powered by NewsLook.com
Tooth Plaque Provides Insight Into Diets Of Ancient People

Tooth Plaque Provides Insight Into Diets Of Ancient People

Newsy (July 19, 2014) Research on plaque from ancient teeth shows that our prehistoric ancestor's had a detailed understanding of plants long before developing agriculture. Video provided by Newsy
Powered by NewsLook.com
Contaminated Water Kills 3 Babies in South African Town

Contaminated Water Kills 3 Babies in South African Town

AFP (July 18, 2014) Contaminated water in South Africa's northwestern town of Bloemhof kills three babies and hospitalises over 500 people. The incident highlights growing fears over water safety in South Africa. Duration: 02:22 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins